These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 29851188)
41. Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study. Lunel-Fabiani F; Mansour W; Amar AO; Aye M; Le Gal F; Malick FZ; Baïdy L; Brichler S; Veillon P; Ducancelle A; Gordien E; Rosenheim M J Infect; 2013 Nov; 67(5):448-57. PubMed ID: 23796871 [TBL] [Abstract][Full Text] [Related]
42. [The analysis of hepatitis delta virus infective markers in the hepatitis is B virus infective people]. Xu PS; Han SY; Sun CY; Zhao J Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):307-9. PubMed ID: 23189853 [TBL] [Abstract][Full Text] [Related]
43. Can We Predict Sustained Virologic Response to Interferon α Therapy in Patients With Chronic Hepatitis Delta Virus Infection? Scholtès C; Kumar R; Zoulim F Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2350-2. PubMed ID: 26254201 [No Abstract] [Full Text] [Related]
44. Meta-analysis: antiviral treatment for hepatitis D. Triantos C; Kalafateli M; Nikolopoulou V; Burroughs A Aliment Pharmacol Ther; 2012 Mar; 35(6):663-73. PubMed ID: 22273482 [TBL] [Abstract][Full Text] [Related]
45. Characterization of hepatitis B and delta coinfection in Israel. Shirazi R; Ram D; Rakovsky A; Bucris E; Gozlan Y; Lustig Y; Shaked-Mishan P; Picard O; Shemer-Avni Y; Ben-Zvi H; Halutz O; Lurie Y; Veizman E; Carlebach M; Braun M; Naftaly MC; Shlomai A; Safadi R; Mendelson E; Sklan EH; Ben-Ari Z; Mor O BMC Infect Dis; 2018 Feb; 18(1):97. PubMed ID: 29486716 [TBL] [Abstract][Full Text] [Related]
46. Genotype characterization of occult hepatitis B virus strains among Egyptian chronic hepatitis C patients. Kishk R; Atta HA; Ragheb M; Kamel M; Metwally L; Nemr N East Mediterr Health J; 2014 Mar; 20(2):130-8. PubMed ID: 24945562 [TBL] [Abstract][Full Text] [Related]
47. Hepatitis delta and HIV infection. Calle Serrano B; Manns MP; Wedemeyer H Semin Liver Dis; 2012 May; 32(2):120-9. PubMed ID: 22760651 [TBL] [Abstract][Full Text] [Related]
48. A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus-infected mongolians. Chen X; Oidovsambuu O; Liu P; Grosely R; Elazar M; Winn VD; Fram B; Boa Z; Dai H; Dashtseren B; Yagaanbuyant D; Genden Z; Dashdorj N; Bungert A; Dashdorj N; Glenn JS Hepatology; 2017 Dec; 66(6):1739-1749. PubMed ID: 27880976 [TBL] [Abstract][Full Text] [Related]
49. Correlation between TH1 response standard cytokines as biomarkers in patients with the delta virus in the western Brazilian Amazon. Nicolete LD; Borzacov LM; Vieira DS; Nicolete R; Salcedo JM Mem Inst Oswaldo Cruz; 2016 Apr; 111(4):275-6. PubMed ID: 27074258 [TBL] [Abstract][Full Text] [Related]
50. Hepatitis D virus and hepatitis B virus infection in Amerindian communities of the Amazonas state, Colombia. di Filippo Villa D; Cortes-Mancera F; Payares E; Montes N; de la Hoz F; Arbelaez MP; Correa G; Navas MC Virol J; 2015 Oct; 12():172. PubMed ID: 26497287 [TBL] [Abstract][Full Text] [Related]
51. Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin. Levast M; Larrat S; Thelu MA; Nicod S; Plages A; Cheveau A; Zarski JP; Seigneurin JM; Morand P; Leroy V J Med Virol; 2010 May; 82(5):747-54. PubMed ID: 20336715 [TBL] [Abstract][Full Text] [Related]
55. Uncontrolled hepatitis delta virus infection after initial suppression on tenofovir in a HIV/HBV-coinfected patient. Béguelin C; Vazquez M; Moradpour D; Sahli R; Suter F; Rauch A; Wandeler G AIDS; 2016 Jan; 30(3):530-2. PubMed ID: 26760236 [No Abstract] [Full Text] [Related]
56. Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up. Yu ML; Lee CM; Chen CL; Chuang WL; Lu SN; Liu CH; Wu SS; Liao LY; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Su WW; Lin CL; Yang HC; Chen PJ; Chen DS; Liu CJ; Hepatology; 2013 Jun; 57(6):2135-42. PubMed ID: 23322699 [TBL] [Abstract][Full Text] [Related]
57. Perspectives on dual hepatitis B and C infection in Taiwan. Liu CJ; Chen PJ; Chen DS; Tseng TC; Kao JH J Formos Med Assoc; 2016 May; 115(5):298-305. PubMed ID: 26188762 [TBL] [Abstract][Full Text] [Related]
58. Hepatitis delta in HIV/HBV co-infected patients in Brazil: is it important? Mendes-Correa MC; Gomes-Gouvêa MS; Alvarado-Mora MV; Da Silva MH; Lázari C; Cavalcanti NC; Alonso FK; Carpinelli CC; Uip DE; Pinho JR Int J Infect Dis; 2011 Dec; 15(12):e828-32. PubMed ID: 21999909 [TBL] [Abstract][Full Text] [Related]
59. Prevalence of hepatitis B and hepatitis D coinfection in asymptomatic blood donors in Iran. Attaran MS; Sharifi Z; Hosseini SM; Samei S; Ataee Z APMIS; 2014 Mar; 122(3):243-7. PubMed ID: 23879563 [TBL] [Abstract][Full Text] [Related]
60. Forty-Five Years after the Discovery of the Hepatitis D Virus: Where Do We Stand? Rizzetto M; Stroffolini T Viruses; 2021 Mar; 13(4):. PubMed ID: 33810224 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]